GSDMA and neoplasm: Evidence suggests that intratumoral delivery of nanoparticle-conjugated, pre-cleaved GSDMA selectively causes tumor cell pyroptosis due to its N-terminal domains, which forms pores by binding to acidic phospholipids in cell membranes [22, 23].